Federico Lucantoni

ResearcherID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 6

Top Venues

Cell death & disease

Cancers

The Journal of pathology

Cell death and differentiation

University of Valencia

Royal College of Surgeons in Ireland (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Valencia

Spain

Postdoctoral researcher :: Pharmacology dept.

Royal College of Surgeons in Ireland

Ireland

Postdoctoral researcher :: Physiology and Medical Physics

Education History

Royal College of Surgeons in Ireland - Oct 06 2017

Ireland

PHD :: Physiology and Medical Physics

Università degli Studi di Roma Tor Vergata Dipartimento di Biologia

Italy

MSC

Università degli Studi di Roma Tor Vergata Dipartimento di Biologia

Italy

BSC

Publications

Federico Lucantoni, Ana M Benedicto, Aleksandra Gruevska, Ángela B Moragrega, Isabel Fuster-Martínez, Juan V Esplugues, Ana Blas-Garcia, Nadezda Apostolova
Implication of autophagy in the antifibrogenic effect of Rilpivirine: when more is less. Cell death & disease 13 (4) (2022)
Federico Lucantoni, Andreu Martínez-Cerezuela, Aleksandra Gruevska, Ángela B Moragrega, Víctor M Víctor, Juan V Esplugues, Ana Blas-García, Nadezda Apostolova
Understanding the implication of autophagy in the activation of hepatic stellate cells in liver fibrosis: are we there yet? The Journal of pathology 254 (3) (2021)
Ignacio Muñoz Resta, Federico Lucantoni, Nadezda Apostolova, Francisco Galindo
Fluorescent styrylpyrylium probes for the imaging of mitochondria in live cells. Organic & biomolecular chemistry 19 (41) (2021)
Alice C O'Farrell, Monika A Jarzabek, Andreas U Lindner, Steven Carberry, Emer Conroy, Ian S Miller, Kate Connor, Liam Shiels, Eugenia R Zanella, Federico Lucantoni, Adam Lafferty, Kieron White, Mariangela Meyer Meyer Villamandos, Patrick Dicker, William M Gallagher, Simon A Keek, Sebastian Sanduleanu, Philippe Lambin, Henry C Woodruff, Andrea Bertotti, Livio Trusolino, Annette T Byrne, Jochen H M Prehn
Implementing Systems Modelling and Molecular Imaging to Predict the Efficacy of BCL-2 Inhibition in Colorectal Cancer Patient-Derived Xenograft Models. Cancers 12 (10) (2020)
Federico Lucantoni, Manuela Salvucci, Heiko Düssmann, Andreas U Lindner, Diether Lambrechts, Jochen H M Prehn
BCL(X)L and BCL2 increase the metabolic fitness of breast cancer cells: a single-cell imaging study. Cell death and differentiation 28 (5) (2020)
Federico Lucantoni, Andreas U Lindner, Norma O'Donovan, Heiko Düssmann, Jochen H M Prehn
Systems modeling accurately predicts responses to genotoxic agents and their synergism with BCL-2 inhibitors in triple negative breast cancer cells. Cell death & disease 9 (2) (2018)

Federico Lucantoni.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Federico Lucantoni